DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
Authors:
- I Muñoz-RepetoIMI Muñoz-Repeto
- D RicoDRD Rico
- A OsorioAOA Osorio
- M UriosteMUM Urioste
- J García-DonasJGJ García-Donas
- S HernandoSHS Hernando
- L Robles-DíazLRL Robles-Díaz
- T Ramón Y CajalTCT Ramón Y Cajal
- A CazorlaACA Cazorla
- R SáezRSR Sáez
- J M García-BuenoJGJ M García-Bueno
Open Access
- 4 April 2013
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 108 (8) , 1732-1742
Abstract
Few studies have attempted to characterise genomic changes occurring in hereditary epithelial ovarian carcinomas (EOCs) and inconsistent results have been obtained. Given the relevance of DNA copy number alterations in ovarian oncogenesis and growing clinical implications of the BRCA-gene status, we aimed to characterise the genomic profiles of hereditary and sporadic ovarian tumours. High-resolution array Comparative Genomic Hybridisation profiling of 53 familial (21 BRCA1, 6 BRCA2 and 26 non-BRCA1/2) and 15 sporadic tumours in combination with supervised and unsupervised analysis was used to define common and/or specific copy number features. Unsupervised hierarchical clustering did not stratify tumours according to their familial or sporadic condition or to their BRCA1/2 mutation status. Common recurrent changes, spanning genes potentially fundamental for ovarian carcinogenesis, regardless of BRCA mutations, and several candidate subtype-specific events were defined. Despite similarities, greater contribution of losses was revealed to be a hallmark of BRCA1 and BRCA2 tumours. Somatic alterations occurring in the development of familial EOCs do not differ substantially from the ones occurring in sporadic carcinomas. However, some specific features like extensive genomic loss observed in BRCA1/2 tumours may be of clinical relevance helping to identify BRCA-related patients likely to respond to PARP inhibitors.Keywords
This publication has 46 references indexed in Scilit:
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupJournal of Clinical Oncology, 2012
- The Changing View of High-Grade Serous Ovarian CancerCancer Research, 2012
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian CancerJAMA, 2012
- A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patientsBreast Cancer Research and Treatment, 2011
- The genesis and evolution of high-grade serous ovarian cancerNature Reviews Cancer, 2010
- MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2PLOS ONE, 2010
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizationsGenes, Chromosomes and Cancer, 2008
- Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancerGenes, Chromosomes and Cancer, 2006
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002